2.1% Above Target

Wall Street's consensus price target for NEWT is $14, -2.1% from its current price of $14.3. The below-market target from 9 analysts suggests limited near-term appreciation.

NEWT has a consensus rating of "Hold" based on 9 Wall Street analysts. The rating breakdown is mixed, with 8 Hold ratings making up the largest segment. The consensus 12-month price target of $14 implies -2.1% downside from current levels.

With a forward P/E of 6.0668x, NEWT trades at a relatively low valuation. The consensus target of $14 implies -2.1% move, suggesting the market may be pricing in risks.

The most bullish Wall Street analyst has a price target of $14 for NEWT, while the most conservative target is $14. The consensus of $14 represents the median expectation. Our quantitative valuation model projects a bull case target of $30 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

NEWT is moderately covered, with 9 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 8 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month NEWT stock forecast based on 9 Wall Street analysts shows a consensus price target of $14, with estimates ranging from $14 (bear case) to $14 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $23, with bear/bull scenarios of $14/$30.

Our quantitative valuation model calculates NEWT's fair value at $23 (base case), with a bear case of $14 and bull case of $30. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 48/100.

NEWT trades at a forward P/E ratio of 6.1x based on next-twelve-months earnings estimates compared to a trailing P/E of 6.1x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Analysts are cautious on NEWT, with 0 Sell ratings and a price target of $14 (-2.1% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

NEWT analyst price targets range from $14 to $14, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $14 consensus represents the middle ground. Our model's $14-$30 range provides an independent fundamental perspective.